2016 Update of the Portuguese Recommendations for the Use of Biological Therapies in Children and Adolescents with Juvenile Idiopathic Arthritis

To provide evidence-based guidance for the rational and safe prescription of biological therapies in children and adolescents with juvenile idiopathic arthritis (JIAs) considering the latest available evidence and the new licensed biologics. Rheumatologists and Pediatricians with expertise in Pediat...

ver descrição completa

Detalhes bibliográficos
Autor principal: Santos, MJ (author)
Outros Autores: Conde, M (author), Mourão, AF (author), Ramos, FO (author), Cabral, M (author), Brito, I (author), Ramos, MP (author), Marques, RC (author), Gomes, SM (author), Guedes, M (author), Gonçalves, MJ (author), Estanqueiro, P (author), Zilhão, C (author), Rodrigues, M (author), Henriques, C (author), Salgado, M (author), Canhão, H (author), Fonseca, JE (author), Gomes, JM (author)
Formato: article
Idioma:eng
Publicado em: 2017
Assuntos:
Juvenile Idiopathic Arthritis
Biological Agents
Child
Adolescent
HDE REUM PED
Texto completo:http://hdl.handle.net/10400.17/2657
País:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/2657

Texto Completo

http://hdl.handle.net/10400.17/2657

Registos relacionados